Trial Information

Summary: A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Status: No longer recruiting

Protocol Number: BA18492

Sponsor: Hoffmann-La Roche

Company Division: Pharmaceutical

Official Scientific Title: Double-blind,placebo-controlled,randomized, multicenter study to assess the efficiency and safety of oral ibandronate 150 mg once monthly in postmenopausal women with osteopenia

Brief Summary: This 2 arm study will evaluate the efficacy and safety of oral Bonviva 150mg once monthly compared with placebo in post-menopausal women with osteopenia. Patients will be randomized to receive either Bonviva 150mg po monthly, or placebo monthly. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals. Target sample size is 160.

Study Phase: IV

Study Design / Study Details:

• Purpose: Treatment
• Allocation: Randomized
• Masking: Double Blind
• Control: Placebo
• Assignment: Parallel
• Endpoints: Safety/Efficacy

Study Type:

Condition: Post-Menopausal Osteopenia

Intervention Type: Drug

Intervention Name: ibandronate [Bonviva/Boniva]

Primary Outcome: 1. Relative change in mean lumbar spine bone mineral density (BMD) Time frame: 12 months

Key Secondary Outcomes: 1. Absolute change in mean lumbar spine BMD Time frame: 12 months 2. Relative and absolute change in mean proximal femur BMD Time frame: 12 months 3. Percentage of responders Time frame: 12 months 4. Relative and absolute change in serum CTX Time frame: 12 months 5. AEs and laboratory parameters Time frame: Throughout study

Inclusion Criteria:

Exclusion Criteria:

Gender: Females

Age Limits: Min: 45 Years Max: 60 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: December, 2005

Trial Registration Date: 10/21/2005

Date Last Updated: 08/18/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 2, 2008 at 2:14:26 PM